Evidence map›Paper›PMID 19709398›Full record

ArticleBMC biology2009

delta-Opioid receptor activation attenuates oxidative injury in the ischemic rat brain.

Yilin Yang, Xiwei Xia, Yi Zhang, Qiang Wang, Lu Li, Guanghua Luo, Ying Xia

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
5.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A Rationale for Hypoxic and Chemical Conditioning in Huntington's Disease.International journal of molecular sciences · 2021
    Review
  6. [D-AlaMediators of inflammation · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. PI3K/Akt Pathway: A Role in δ-Opioid Receptor-Mediated RGC Neuroprotection.Investigative ophthalmology & visual science · 2017
    Article
  12. Opioids Resistance in Chronic Pain Management.Current neuropharmacology · 2017
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yilin YangThird Clinical College of Schoow University, Changzhou, Jiangsu, PR China. bigyang@vip.sina.com
Xiwei Xia
Yi Zhang
Qiang Wang
Lu Li
Guanghua Luo
Ying Xia
Changzhou University · CNYale University · US

Funding

Hypoxia &Neuronal Excitability: Cellular MechanismsR01HD034852 · NICHD · YALE UNIVERSITY · PI XIA, YING · 1997 to 2012
$3.5M
A new strategy for protection from cerebral ischemiaR01AT004422 · NCCIH · YALE UNIVERSITY · PI XIA, YING · 2009 to 2013
$1.9M
NCCIH NIH HHS NIH-AT004422NCCIH NIH HHS R01 AT004422NICHD NIH HHS NIH-HD34852NICHD NIH HHS R01 HD034852
6 · The paper itself

Abstract

backgroundWe have recently shown that delta-opioid receptors (DORs) play an important role in neuroprotection from hypoxic injury via the regulation of extracellular signaling-regulated kinase (ERK) and cytochrome c release. Since ERK and cytochrome c are differentially involved in caspase signaling of oxidative injury that significantly contributes to neuronal damage in ischemia/reperfusion, we considered if DOR activation protects the ischemic brain by attenuating oxidative injury.

resultsWe observed that, in a model of cerebral ischemia with middle cerebral artery occlusion, DOR activation increased the activity of major antioxidant enzymes, glutathione peroxidase and superoxide dismutase, and decreased malondialdehyde and nitric oxide levels in the cortex exposed to cerebral ischemia/reperfusion. In addition, DOR activation reduced caspase 3 expression, though it did not significantly affect the increase in interleukin (IL)1beta and tumor necrosis factor (TNF)alpha expression at the same timepoint. PD98059, an inhibitor of mitogen-activated protein kinase (MAPK) extracellular signaling-regulated kinase kinase, accelerated animal death during ischemia/reperfusion.

conclusionDOR activation attenuates oxidative injury in the brain exposed to ischemia/reperfusion by enhancing antioxidant ability and inhibiting caspase activity, which provides novel insights into the mechanism of DOR neuroprotection.

Indexed as

Oxidative StressAnimalsBrain IschemiaCaspase 3Enkephalin, Leucine-2-AlanineGene Expression RegulationGlutathione PeroxidaseHippocampusInterleukin-1betaMaleMalondialdehydeModels, BiologicalNitric OxideRatsRats, Sprague-DawleyReceptors, Opioid, deltaCaspase 3Enkephalin, Leucine-2-AlanineGlutathione PeroxidaseInterleukin-1betaMalondialdehydeNitric OxideReceptors, Opioid, deltaRNA, MessengerSuperoxide DismutaseTumor Necrosis Factor-alpha

Identifiers

PMID19709398
PMCPMC2754429
OpenAlexW2039086621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.